- Home
- PEN vs NLY Comparison
PEN vs NLY Comparison
Compare PEN & NLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- NLY
- Stock Information
- Founded
- PEN 2004
- NLY 1996
- Country
- PEN United States
- NLY United States
- Employees
- PEN N/A
- NLY N/A
- Industry
- PEN Medical/Dental Instruments
- NLY Real Estate Investment Trusts
- Sector
- PEN Health Care
- NLY Real Estate
- Exchange
- PEN Nasdaq
- NLY Nasdaq
- Market Cap
- PEN 9.1B
- NLY 10.3B
- IPO Year
- PEN 2015
- NLY 1997
- Fundamental
- Price
- PEN $268.17
- NLY $19.51
- Analyst Decision
- PEN Buy
- NLY Strong Buy
- Analyst Count
- PEN 16
- NLY 11
- Target Price
- PEN $262.87
- NLY $21.20
- AVG Volume (30 Days)
- PEN 423.0K
- NLY 7.8M
- Earning Date
- PEN 02-20-2025
- NLY 01-29-2025
- Dividend Yield
- PEN N/A
- NLY 13.36%
- EPS Growth
- PEN N/A
- NLY N/A
- EPS
- PEN 0.89
- NLY N/A
- Revenue
- PEN $1,163,776,000.00
- NLY $369,368,000.00
- Revenue This Year
- PEN $13.55
- NLY N/A
- Revenue Next Year
- PEN $14.48
- NLY $9.79
- P/E Ratio
- PEN $302.85
- NLY N/A
- Revenue Growth
- PEN 16.96
- NLY N/A
- 52 Week Low
- PEN $148.00
- NLY $17.67
- 52 Week High
- PEN $277.34
- NLY $21.11
- Technical
- Relative Strength Index (RSI)
- PEN 68.37
- NLY 59.28
- Support Level
- PEN $237.65
- NLY $17.76
- Resistance Level
- PEN $260.88
- NLY $19.04
- Average True Range (ATR)
- PEN 9.75
- NLY 0.32
- MACD
- PEN 2.18
- NLY 0.13
- Stochastic Oscillator
- PEN 94.76
- NLY 98.87
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. The Company owns a portfolio of real estate related investments, including mortgage pass-through certificates, collateralized mortgage obligations, credit risk transfer securities, other securities representing interests in or obligations backed by pools of mortgage loans, residential mortgage loans and mortgage servicing rights. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The Company's three investment groups are comprised of the following: Annaly Agency Group, Annaly Residential Credit Group, Annaly Mortgage Servicing Rights Group.